← All stocks

Coherus Oncology, Inc.

CHRS No buying or selling

CIK 0001512762 #3931 in the set updated 22 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lanfear Dennis M

President & CEO

—

1,048,235

0.6785%

$774.54K

+47.9%

McMichael Bryan J

Chief Financial Officer

—

133,736

0.0866%

$98.82K

+407.1%

Reider Paul

Chief Commercial Officer

—

82,069

0.0531%

$60.64K

−10.1%

Satvat Ali J.

Director

—

30,000

0.0194%

$22.17K

—

Newton Charles W.

Director

—

30,000

0.0194%

$22.17K

—

Wahlstrom Mats

Director

—

30,000

0.0194%

$22.17K

−70.0%

Newcomer Lee Nisley

Director

—

30,000

0.0194%

$22.17K

—

Karachun Rita A

Director

—

30,000

0.0194%

$22.17K

—

Ryan Michael Lee

Director

—

30,000

0.0194%

$22.17K

—

O'Donnell-Tormey Jill

Director

—

30,000

0.0194%

$22.17K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 13

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 711,054

History held since 6 Sep 2016